How can agencies best entice clients to incorporate behavioral science into their marketing programs?
How can marketers incorporate patient feedback into their marketing strategies without expensive and time-consuming studies?
Nothing is more personal than an individual's health; the technology that will prove most effective will be solutions that are personal.
With rep access to physicians on the decline, what are the most effective non-personal promotional tactics marketers can use to connect with prescribers?
We should make off-label research publicly available in a non-promotional format to both healthcare professionals and patients.
Data analytics, relationship building, and improved patient support are the keys to differentiating your rare-disease drug brands, according to these four marketers.
Does virtual reality represent a new way for marketers to create immersive experiences — or is this just the industry's latest shiny object?
Pharma must be thoughtful in its approach and demonstrate value to be part of the EHR conversation.
It's been called "America's other drug problem."
Pharma marketing has long been deemed slow to adapt. Last weekend's Lions Health festival offered a glimpse of healthcare as a first mover.
The traditional line of attack is genuine and requires little in the way of spin—yet still, every time a Turing rears its head, it gets blown back in small and indigestible pieces.
If more physicians begin participating in late-phase research efforts—and work to educate patients about these opportunities—we can expect new innovations in treatment solutions to come more quickly to market.
There is an immediate need for greater education regarding halal and vaccines for Muslim consumers worldwide.
Although the industry wants to help patients get healthy - and wants to be a critical part in that process - there's a delicate balance to strike between selling product and achieving healthier outcomes.
We need to view the patient journey as a starting place for much deeper analysis.
When Monique Levy, one of the most-level-headed analysts in the pharma industry, calls attention to a mysterious phenomenon, you listen.
Why healthcare brands need to start speaking in video, and how they can do it
Agencies struggle to find VPs of digital strategy (or multichannel strategy or engagement strategy) because they don't really need one.
"In this fast-moving environment, we believe these five guidelines will help guide your clinical trial team in taking full advantage of this exciting new platform."
The healthcare ecosystem is changing rapidly to succeed requires the adoption of key account management (KAM), a systematic, robust alternative to the traditional buyer/seller model.
How the adoption of principles from recent, successful start ups can be applied to pharma marketing.
Key trends from the latest Consumer Electronics Show through the eyes of NostaLab's John Nosta
"Although the United States represents almost half of the biologics market in terms of revenue and volume, biosimilars growth will be fueled by focusing on the emerging markets, by addressing non-consumption and patient inability to pay for high-priced biologics."
"The trouble is that the market is changing much faster than most marketers realize."
"Customer service is more than just a nice-to-have. In this competitive marketplace, it can mean the difference between your brand or someone else's."
"We are living in an era of great medical technological innovations. However, this is shifting healthcare back home and expecting patients to understand excessive medical information and follow complex instructions."
- Five things for pharma marketers to know: Wednesday, March 22, 2017
- Five things for pharma marketers to know: Monday, March 20, 2017
- Drugmakers target severe asthma patients with biologics, but payers raise pricing issue
- Novartis aims to bring first oral asthma drug to market in two decades
- What five different pharma marketing careers look like
- 2017 Healthcare Marketers Trend Report: All the data in one place
- Infographic: What's next for the point of care market
- Drugmakers again boost DTC spending, to $5.6 billion in 2016
- Digital IDs become focus as drugmakers seek to track doctors' behavior online
- Some CME experts remain skeptical when it comes to social media